Company Filing History:
Years Active: 2011-2021
Title: Lee Alan Henderson: Innovator in Huntington's Disease Research
Introduction
Lee Alan Henderson is a notable inventor based in Ithaca, NY (US), recognized for his contributions to the field of biomedical research. He holds three patents that focus on innovative solutions for poly-glutamate associated diseases, particularly Huntington's disease. His work aims to address the challenges posed by protein aggregation and gene dysregulation in affected individuals.
Latest Patents
Henderson's latest patents include compositions and methods for single chain intrabodies that alter the degradation of the huntingtin mutant. These intrabodies are designed to bind and modify the effects of poly-glutamate protein aggregation, which is a significant factor in the progression of Huntington's disease. By preventing poly-glutamate aggregation and its associated negative effects, his inventions offer promising avenues for therapeutic intervention.
Career Highlights
Henderson is currently affiliated with Vybion, Inc., where he continues to advance his research and development efforts. His innovative approach to tackling complex biomedical issues has positioned him as a key figure in the fight against Huntington's disease.
Collaborations
Some of his notable coworkers include Irene Alexandra Amaro and Leo B Kriksunov, who contribute to the collaborative environment at Vybion, Inc. Their combined expertise enhances the potential for groundbreaking discoveries in the field.
Conclusion
Lee Alan Henderson's work exemplifies the impact of innovation in addressing critical health challenges. His patents and ongoing research are paving the way for new treatments for Huntington's disease, showcasing the importance of scientific advancement in improving patient outcomes.